Concepts (203)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Duodenum | 1 | 2024 | 42 | 0.930 |
Why?
|
| Abdominal Injuries | 1 | 2024 | 30 | 0.910 |
Why?
|
| Tissue Engineering | 6 | 2017 | 134 | 0.860 |
Why?
|
| Crisis Intervention | 1 | 2021 | 26 | 0.740 |
Why?
|
| Blood Vessel Prosthesis | 7 | 2017 | 215 | 0.700 |
Why?
|
| Thoracostomy | 1 | 2020 | 8 | 0.680 |
Why?
|
| Pleurodesis | 1 | 2020 | 9 | 0.680 |
Why?
|
| Thoracic Surgery, Video-Assisted | 1 | 2020 | 54 | 0.650 |
Why?
|
| Pneumothorax | 1 | 2020 | 49 | 0.650 |
Why?
|
| Inpatients | 1 | 2021 | 291 | 0.620 |
Why?
|
| Child | 16 | 2024 | 4174 | 0.600 |
Why?
|
| Hospitalization | 9 | 2024 | 1290 | 0.570 |
Why?
|
| Venous Thromboembolism | 3 | 2023 | 141 | 0.490 |
Why?
|
| Adolescent | 13 | 2024 | 5824 | 0.490 |
Why?
|
| Cross-Sectional Studies | 10 | 2024 | 2373 | 0.450 |
Why?
|
| Blood Vessels | 1 | 2012 | 62 | 0.380 |
Why?
|
| Infant | 7 | 2024 | 1486 | 0.350 |
Why?
|
| Craniocerebral Trauma | 3 | 2020 | 56 | 0.350 |
Why?
|
| Wounds and Injuries | 2 | 2023 | 229 | 0.330 |
Why?
|
| Skiing | 2 | 2020 | 11 | 0.320 |
Why?
|
| Specialties, Surgical | 2 | 2020 | 45 | 0.310 |
Why?
|
| Tissue Scaffolds | 6 | 2017 | 79 | 0.310 |
Why?
|
| Athletic Injuries | 2 | 2020 | 71 | 0.300 |
Why?
|
| Firearms | 2 | 2019 | 54 | 0.300 |
Why?
|
| Crohn Disease | 2 | 2020 | 106 | 0.300 |
Why?
|
| Female | 20 | 2025 | 30705 | 0.280 |
Why?
|
| Male | 17 | 2025 | 27739 | 0.280 |
Why?
|
| Child, Preschool | 5 | 2024 | 1782 | 0.280 |
Why?
|
| Databases, Factual | 4 | 2024 | 813 | 0.280 |
Why?
|
| Injury Severity Score | 2 | 2024 | 101 | 0.260 |
Why?
|
| Retrospective Studies | 9 | 2024 | 6071 | 0.260 |
Why?
|
| Models, Animal | 3 | 2017 | 221 | 0.260 |
Why?
|
| Portal Vein | 2 | 2017 | 38 | 0.250 |
Why?
|
| Humans | 26 | 2025 | 59360 | 0.250 |
Why?
|
| Length of Stay | 3 | 2024 | 775 | 0.240 |
Why?
|
| United States | 9 | 2024 | 7390 | 0.240 |
Why?
|
| Cultural Diversity | 1 | 2025 | 52 | 0.220 |
Why?
|
| Bariatric Surgery | 1 | 2024 | 52 | 0.220 |
Why?
|
| Career Choice | 1 | 2025 | 120 | 0.210 |
Why?
|
| Obesity, Morbid | 1 | 2024 | 92 | 0.210 |
Why?
|
| Minority Groups | 1 | 2025 | 135 | 0.210 |
Why?
|
| Accidents, Traffic | 1 | 2024 | 148 | 0.210 |
Why?
|
| Pediatric Obesity | 1 | 2024 | 96 | 0.210 |
Why?
|
| Comorbidity | 3 | 2020 | 1078 | 0.200 |
Why?
|
| General Surgery | 1 | 2025 | 191 | 0.200 |
Why?
|
| Wounds, Gunshot | 2 | 2019 | 52 | 0.200 |
Why?
|
| Head Protective Devices | 2 | 2020 | 19 | 0.190 |
Why?
|
| Tertiary Healthcare | 1 | 2021 | 13 | 0.190 |
Why?
|
| Young Adult | 5 | 2025 | 4267 | 0.180 |
Why?
|
| Surgeons | 2 | 2020 | 161 | 0.180 |
Why?
|
| Snow Sports | 1 | 2020 | 3 | 0.170 |
Why?
|
| Cerebral Intraventricular Hemorrhage | 1 | 2020 | 9 | 0.170 |
Why?
|
| Infant Mortality | 1 | 2020 | 19 | 0.170 |
Why?
|
| Sex Factors | 2 | 2020 | 935 | 0.170 |
Why?
|
| Chest Tubes | 1 | 2020 | 16 | 0.170 |
Why?
|
| Ductus Arteriosus, Patent | 1 | 2020 | 13 | 0.170 |
Why?
|
| Deficiency Diseases | 1 | 2019 | 12 | 0.170 |
Why?
|
| Play and Playthings | 1 | 2019 | 20 | 0.160 |
Why?
|
| Bites and Stings | 1 | 2019 | 11 | 0.160 |
Why?
|
| Enterocolitis, Necrotizing | 1 | 2019 | 16 | 0.160 |
Why?
|
| Social Class | 1 | 2020 | 122 | 0.160 |
Why?
|
| Age Factors | 2 | 2021 | 1504 | 0.160 |
Why?
|
| Accidental Falls | 1 | 2020 | 124 | 0.160 |
Why?
|
| Patient Compliance | 1 | 2021 | 349 | 0.160 |
Why?
|
| Infant, Premature, Diseases | 1 | 2019 | 45 | 0.160 |
Why?
|
| Respiratory System Abnormalities | 1 | 2018 | 3 | 0.160 |
Why?
|
| Infant, Newborn | 5 | 2020 | 1283 | 0.150 |
Why?
|
| Referral and Consultation | 1 | 2021 | 398 | 0.150 |
Why?
|
| Dogs | 1 | 2019 | 314 | 0.150 |
Why?
|
| Intensive Care Units, Neonatal | 1 | 2018 | 75 | 0.150 |
Why?
|
| Inflammatory Bowel Diseases | 1 | 2019 | 95 | 0.140 |
Why?
|
| Suicide | 1 | 2019 | 119 | 0.140 |
Why?
|
| Lung Diseases | 1 | 2018 | 170 | 0.140 |
Why?
|
| Radiography | 1 | 2018 | 517 | 0.130 |
Why?
|
| Risk Factors | 6 | 2023 | 4984 | 0.130 |
Why?
|
| Cardiac Surgical Procedures | 1 | 2020 | 249 | 0.130 |
Why?
|
| Mass Screening | 1 | 2021 | 645 | 0.130 |
Why?
|
| Dioxoles | 1 | 2015 | 2 | 0.120 |
Why?
|
| Receptors, Transforming Growth Factor beta | 1 | 2015 | 29 | 0.120 |
Why?
|
| Nanofibers | 1 | 2015 | 17 | 0.120 |
Why?
|
| Neurons | 3 | 2004 | 863 | 0.120 |
Why?
|
| Benzamides | 1 | 2015 | 63 | 0.120 |
Why?
|
| Constriction, Pathologic | 1 | 2015 | 112 | 0.120 |
Why?
|
| Receptors, Nicotinic | 2 | 2004 | 66 | 0.110 |
Why?
|
| Patient Acceptance of Health Care | 1 | 2018 | 450 | 0.110 |
Why?
|
| Nanotechnology | 1 | 2015 | 127 | 0.110 |
Why?
|
| Mesenteric Veins | 1 | 2013 | 11 | 0.110 |
Why?
|
| Hippocampus | 2 | 2004 | 246 | 0.100 |
Why?
|
| Animals | 11 | 2019 | 19651 | 0.100 |
Why?
|
| Catheterization, Central Venous | 1 | 2013 | 84 | 0.100 |
Why?
|
| Nanomedicine | 1 | 2012 | 24 | 0.100 |
Why?
|
| Venous Thrombosis | 1 | 2013 | 110 | 0.100 |
Why?
|
| Fibrinolytic Agents | 1 | 2013 | 163 | 0.100 |
Why?
|
| Thrombolytic Therapy | 1 | 2013 | 184 | 0.090 |
Why?
|
| Bone Marrow Cells | 1 | 2012 | 234 | 0.090 |
Why?
|
| Biocompatible Materials | 1 | 2012 | 141 | 0.090 |
Why?
|
| Internship and Residency | 1 | 2018 | 746 | 0.090 |
Why?
|
| ROC Curve | 2 | 2021 | 266 | 0.080 |
Why?
|
| Infant, Premature | 2 | 2020 | 175 | 0.070 |
Why?
|
| Multivariate Analysis | 2 | 2020 | 902 | 0.070 |
Why?
|
| Registries | 2 | 2021 | 801 | 0.070 |
Why?
|
| Mice | 7 | 2017 | 10292 | 0.060 |
Why?
|
| Logistic Models | 2 | 2019 | 1232 | 0.060 |
Why?
|
| Amitriptyline | 1 | 2004 | 7 | 0.060 |
Why?
|
| Antidepressive Agents, Tricyclic | 1 | 2004 | 19 | 0.060 |
Why?
|
| Intermediate Filament Proteins | 1 | 2004 | 19 | 0.060 |
Why?
|
| Olfactory Bulb | 1 | 2004 | 15 | 0.060 |
Why?
|
| Needs Assessment | 1 | 2025 | 187 | 0.050 |
Why?
|
| Transgenes | 1 | 2004 | 177 | 0.050 |
Why?
|
| Cardiovascular Diseases | 1 | 2011 | 788 | 0.050 |
Why?
|
| Behavior, Animal | 1 | 2004 | 215 | 0.050 |
Why?
|
| Stem Cells | 1 | 2004 | 255 | 0.050 |
Why?
|
| Trauma Centers | 1 | 2023 | 113 | 0.050 |
Why?
|
| Nerve Tissue Proteins | 1 | 2004 | 418 | 0.050 |
Why?
|
| Glasgow Coma Scale | 1 | 2021 | 43 | 0.050 |
Why?
|
| Pilot Projects | 1 | 2025 | 914 | 0.050 |
Why?
|
| Promoter Regions, Genetic | 1 | 2004 | 651 | 0.050 |
Why?
|
| DNA-Directed RNA Polymerases | 1 | 2021 | 57 | 0.040 |
Why?
|
| Body Mass Index | 1 | 2024 | 831 | 0.040 |
Why?
|
| Cell Proliferation | 1 | 2004 | 942 | 0.040 |
Why?
|
| Clinical Decision-Making | 1 | 2021 | 146 | 0.040 |
Why?
|
| Perioperative Period | 1 | 2020 | 19 | 0.040 |
Why?
|
| North America | 1 | 2020 | 106 | 0.040 |
Why?
|
| Ligation | 1 | 2020 | 33 | 0.040 |
Why?
|
| Infant, Low Birth Weight | 1 | 2020 | 56 | 0.040 |
Why?
|
| Patient Admission | 1 | 2021 | 184 | 0.040 |
Why?
|
| Torso | 1 | 2019 | 16 | 0.040 |
Why?
|
| Contusions | 1 | 2019 | 11 | 0.040 |
Why?
|
| Eye Injuries | 1 | 2019 | 13 | 0.040 |
Why?
|
| Neonatologists | 1 | 2019 | 1 | 0.040 |
Why?
|
| Intestinal Obstruction | 1 | 2020 | 49 | 0.040 |
Why?
|
| Neck Injuries | 1 | 2019 | 19 | 0.040 |
Why?
|
| Income | 1 | 2020 | 156 | 0.040 |
Why?
|
| Incidence | 1 | 2023 | 1237 | 0.040 |
Why?
|
| Laparotomy | 1 | 2019 | 47 | 0.040 |
Why?
|
| Fellowships and Scholarships | 1 | 2020 | 98 | 0.040 |
Why?
|
| Adult | 3 | 2025 | 15669 | 0.040 |
Why?
|
| Hospital Costs | 1 | 2019 | 119 | 0.040 |
Why?
|
| X-Rays | 1 | 2018 | 45 | 0.040 |
Why?
|
| Anticoagulants | 1 | 2023 | 477 | 0.040 |
Why?
|
| Predictive Value of Tests | 1 | 2021 | 1025 | 0.040 |
Why?
|
| Combined Modality Therapy | 1 | 2019 | 355 | 0.040 |
Why?
|
| Chi-Square Distribution | 1 | 2019 | 409 | 0.040 |
Why?
|
| Suicide, Attempted | 1 | 2019 | 105 | 0.040 |
Why?
|
| Urban Population | 1 | 2019 | 179 | 0.040 |
Why?
|
| Health Care Surveys | 1 | 2019 | 271 | 0.040 |
Why?
|
| Leadership | 1 | 2020 | 194 | 0.040 |
Why?
|
| Gestational Age | 1 | 2018 | 178 | 0.040 |
Why?
|
| X-Ray Microtomography | 1 | 2017 | 24 | 0.040 |
Why?
|
| Intensive Care Units | 1 | 2021 | 423 | 0.040 |
Why?
|
| Mice, Inbred C57BL | 3 | 2015 | 3231 | 0.040 |
Why?
|
| Rural Population | 1 | 2019 | 185 | 0.040 |
Why?
|
| Ultrasonography | 1 | 2019 | 459 | 0.030 |
Why?
|
| Mice, SCID | 1 | 2017 | 513 | 0.030 |
Why?
|
| Tomography, X-Ray Computed | 2 | 2015 | 1526 | 0.030 |
Why?
|
| Hospital Mortality | 1 | 2020 | 841 | 0.030 |
Why?
|
| Implants, Experimental | 1 | 2015 | 5 | 0.030 |
Why?
|
| Polyglycolic Acid | 1 | 2015 | 16 | 0.030 |
Why?
|
| Reference Standards | 1 | 2015 | 71 | 0.030 |
Why?
|
| Polyesters | 1 | 2015 | 46 | 0.030 |
Why?
|
| Lactic Acid | 1 | 2015 | 71 | 0.030 |
Why?
|
| Risk Assessment | 1 | 2021 | 1921 | 0.030 |
Why?
|
| Critical Care | 1 | 2018 | 397 | 0.030 |
Why?
|
| Sheep | 1 | 2015 | 169 | 0.030 |
Why?
|
| Neovascularization, Physiologic | 1 | 2015 | 101 | 0.030 |
Why?
|
| Aorta | 1 | 2015 | 108 | 0.030 |
Why?
|
| Extracellular Matrix | 1 | 2015 | 132 | 0.030 |
Why?
|
| Endothelium, Vascular | 1 | 2015 | 169 | 0.030 |
Why?
|
| Practice Patterns, Physicians' | 1 | 2019 | 687 | 0.030 |
Why?
|
| Survival Analysis | 1 | 2015 | 555 | 0.030 |
Why?
|
| Lung | 1 | 2018 | 919 | 0.030 |
Why?
|
| Infusions, Intravenous | 1 | 2013 | 164 | 0.030 |
Why?
|
| Surveys and Questionnaires | 1 | 2020 | 2513 | 0.020 |
Why?
|
| Massachusetts | 1 | 2018 | 2002 | 0.020 |
Why?
|
| Polymers | 1 | 2015 | 316 | 0.020 |
Why?
|
| Graft Occlusion, Vascular | 1 | 2011 | 62 | 0.020 |
Why?
|
| Mice, Knockout | 2 | 2004 | 1994 | 0.020 |
Why?
|
| Treatment Outcome | 1 | 2020 | 5284 | 0.020 |
Why?
|
| Macrophages | 1 | 2015 | 1015 | 0.020 |
Why?
|
| Follow-Up Studies | 1 | 2013 | 2337 | 0.020 |
Why?
|
| Blood Vessel Prosthesis Implantation | 1 | 2011 | 297 | 0.020 |
Why?
|
| Time Factors | 1 | 2015 | 3617 | 0.020 |
Why?
|
| Helplessness, Learned | 1 | 2004 | 2 | 0.010 |
Why?
|
| Hindlimb Suspension | 1 | 2004 | 2 | 0.010 |
Why?
|
| Nortriptyline | 1 | 2004 | 3 | 0.010 |
Why?
|
| Gliosis | 1 | 2004 | 27 | 0.010 |
Why?
|
| Mecamylamine | 1 | 2004 | 14 | 0.010 |
Why?
|
| Nicotinic Antagonists | 1 | 2004 | 19 | 0.010 |
Why?
|
| Bromodeoxyuridine | 1 | 2004 | 40 | 0.010 |
Why?
|
| Swimming | 1 | 2004 | 21 | 0.010 |
Why?
|
| Nestin | 1 | 2004 | 13 | 0.010 |
Why?
|
| Cell Count | 1 | 2004 | 127 | 0.010 |
Why?
|
| Cyclic AMP Response Element-Binding Protein | 1 | 2004 | 46 | 0.010 |
Why?
|
| Drug Interactions | 1 | 2004 | 115 | 0.010 |
Why?
|
| Analysis of Variance | 1 | 2004 | 589 | 0.010 |
Why?
|
| Cell Division | 1 | 2004 | 443 | 0.010 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2004 | 806 | 0.010 |
Why?
|
| Immunohistochemistry | 1 | 2004 | 847 | 0.010 |
Why?
|
| Mice, Transgenic | 1 | 2004 | 1206 | 0.010 |
Why?
|
| Apoptosis | 1 | 2004 | 1032 | 0.010 |
Why?
|
| Drosophila Proteins | 1 | 2004 | 679 | 0.010 |
Why?
|
| Aging | 1 | 2004 | 710 | 0.010 |
Why?
|
| Gene Expression Regulation | 1 | 2004 | 1552 | 0.010 |
Why?
|